Crinetics Pharmaceuticals, Inc. employees and revenue per employee

CRNX · Biotechnology · $9.01B market cap

Crinetics Pharmaceuticals, Inc. had 594 employees at the end of fiscal Dec 2025, up 35.9% from a year earlier. Revenue for the year was $7.7M, up 640.7% from a year earlier, or $13K per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

594

+35.9% YoY

Revenue

$7.7M

+640.7% YoY

Revenue / employee

$13K

Peer median $457K

Rank in industry

103 of 110

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2018
06821365'18'19'20'21'22'23'24'25Revenue 317Staff 1264

Hover a year for the numbers.

CRNX employees and revenue by fiscal year
Year endingEmployeesRevenuePer employeeStaff YoYRevenue YoY
Dec 2025594$7.7M$13K+35.9%+640.7%
Dec 2024437$1.0M$2K+50.7%-74.1%
Dec 2023290$4.0M$14K+38.1%-15.3%
Dec 2022210$4.7M$23K+46.9%+339.4%
Dec 2021143$1.1M$8K+53.8%+1418.3%
Dec 202093$71,000$1K+36.8%-94.0%
Dec 201968$1.2M$18K+44.7%-50.9%
Dec 201847$2.4M$52K——

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years
93'20143'21210'22290'23437'24594'25
Revenue per employee, last six fiscal years
$1K'20$8K'21$23K'22$14K'23$2K'24$13K'25

Crinetics Pharmaceuticals, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

CompanyEmployeesRevenueRevenue / employeeShape
CBIO
Crescent Biopharma, Inc.
44$10.8M$246K—
JANX
Janux Therapeutics, Inc.
109$10.0M$92KHiring into decline
PRAX
Praxis Precision Medicines, Inc.
116$8.6M$74KEfficient growth
PGEN
Precigen, Inc.
160$9.7M$61KEfficient growth
ZBIO
Zenas BioPharma, Inc.
167$10.0M$60KEfficient growth
IMNM
Immunome, Inc.
177$6.9M$39KHiring into decline
CGON
CG Oncology Inc.
142$4.0M$28KEfficient growth
CRNX
Crinetics Pharmaceuticals, Inc.
594$7.7M$13KEfficient growth
AKTS
Aktis Oncology, Inc.
200,000$6.5M$32—
Every Healthcare company

Questions about Crinetics Pharmaceuticals, Inc.

How many employees does Crinetics Pharmaceuticals, Inc. have?
Crinetics Pharmaceuticals, Inc. reported 594 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 26, 2026. That is up 35.9% from a year earlier.
What is Crinetics Pharmaceuticals, Inc.'s revenue per employee?
Crinetics Pharmaceuticals, Inc. brought in $7.7M of revenue in fiscal Dec 2025, which is $13K per employee. That ranks 103 of 110 companies we track in Biotechnology, where the median is $457K.
Where do these numbers come from?
Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

This page is the filings. The research is a membership.

On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

Compare CRNX with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Source: employee counts and revenue as stated in Crinetics Pharmaceuticals, Inc.'s annual reports (Form 10-K), latest filed February 26, 2026. This is data, not a recommendation to buy or sell CRNX.